RNA, U4 small nuclear 23, pseudogene (RNU4-23P)

RNA, U4 small nuclear 23, pseudogene (RNU4-23P) is a human gene classified as a pseudogene that would encode a U4 small nuclear RNA (snRNA) if functional[2]. True U4 small nuclear RNA genes are essential non-coding RNAs that participate in the spliceosome complex, mediating pre-mRNA splicing and gene expression regulation through RNA–RNA and RNA–protein interactions. However, RNU4-23P is a non-functional, likely non-expressed pseudogene variant and does not encode a functional RNA or protein. It is not considered a therapeutic target, biomarker, nor implicated in drug interactions, and there is no evidence linking it to disease or therapeutic use. The locus is primarily of genomic and evolutionary interest rather than clinical or pharmacological significance[2]. Explanation: - RNU4-23P is specifically designated as a pseudogene in all available authoritative databases (e.g., NCBI)[2]. - Pseudogenes, by definition, do not produce functional products and are not considered valid therapeutic targets, biomarkers, or involved in drug mechanisms. - There is no evidence of disease association, clinical utility, or interaction with drugs or patient monitoring, nor are there safety concerns related to therapeutics derived from this pseudogene. If you intended to refer to *functional* U4 small nuclear RNAs (such as RNU4-2), those are significant for spliceosome biology and (when mutated) for neurodevelopmental disorders, but this does not apply to the pseudogene RNU4-23P as requested in your query[2][7].

Other names

RNU4-23P